Mark Haas

Summary

Affiliation: Cedars-Sinai Medical Center
Country: USA

Publications

  1. doi request reprint Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies
    Mark Haas
    Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, California, USA Electronic address
    Kidney Int . 2017
  2. pmc A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy
    Mark Haas
    Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, California
    J Am Soc Nephrol 28:691-701. 2017
  3. doi request reprint Emerging Concepts and Controversies in Renal Pathology: C4d-Negative and Arterial Lesions as Manifestations of Antibody-Mediated Transplant Rejection
    Mark Haas
    Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA Electronic address
    Surg Pathol Clin 7:457-67. 2014
  4. doi request reprint Pathology of C4d-negative antibody-mediated rejection in renal allografts
    Mark Haas
    Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, California 91403, USA
    Curr Opin Organ Transplant 18:319-26. 2013
  5. doi request reprint Pathologic features of antibody-mediated rejection in renal allografts: an expanding spectrum
    Mark Haas
    Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, California 91403, USA
    Curr Opin Nephrol Hypertens 21:264-71. 2012
  6. ncbi request reprint C4d-negative antibody-mediated rejection in renal allografts: evidence for its existence and effect on graft survival
    M Haas
    Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Clin Nephrol 75:271-8. 2011
  7. doi request reprint Early ultrastructural changes in renal allografts: correlation with antibody-mediated rejection and transplant glomerulopathy
    M Haas
    Department of Pathology and Laboratory Medicine Biostatistics Core, Research Institute and General Clinical Research Center, Cedars Sinai Medical Center, Los Angeles, CA, USA
    Am J Transplant 11:2123-31. 2011
  8. doi request reprint Glomerular diseases associated with hematopoietic neoplasms: an expanding spectrum
    Mark Haas
    Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    Kidney Int 80:701-3. 2011
  9. doi request reprint The significance of C4d staining with minimal histologic abnormalities
    Mark Haas
    Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    Curr Opin Organ Transplant 15:21-7. 2010
  10. doi request reprint Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies on graft outcome
    Nancy L Reinsmoen
    1 HLA Laboratory, Cedars Sinai Medical Center, Los Angeles, CA 2 Biostatistics Core, Research Institute and General Clinical Research Center and Cardiothoracic Surgery, Cedars Sinai Medical Center, Los Angeles, CA 3 MD Anderson Medical Center, Houston, TX 4 Pathology, Cedars Sinai Medical Center, Los Angeles, CA 5 Cedars Sinai Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA 6 Address correspondence to Nancy L Reinsmoen, Ph D, D ABHI HLA Laboratory, Cedars Sinai Medical Center, 8723 Alden Dr, SSB 197, Los Angeles, CA 90048
    Transplantation 97:595-601. 2014

Collaborators

Detail Information

Publications19

  1. doi request reprint Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies
    Mark Haas
    Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, California, USA Electronic address
    Kidney Int . 2017
    ....
  2. pmc A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy
    Mark Haas
    Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, California
    J Am Soc Nephrol 28:691-701. 2017
    ....
  3. doi request reprint Emerging Concepts and Controversies in Renal Pathology: C4d-Negative and Arterial Lesions as Manifestations of Antibody-Mediated Transplant Rejection
    Mark Haas
    Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA Electronic address
    Surg Pathol Clin 7:457-67. 2014
    ..Recent studies suggest that intimal arteritis may in some cases be a manifestation of DSA-induced graft injury. These newly recognized lesions of AMR have now been incorporated into a revised Banff diagnostic schema. ..
  4. doi request reprint Pathology of C4d-negative antibody-mediated rejection in renal allografts
    Mark Haas
    Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, California 91403, USA
    Curr Opin Organ Transplant 18:319-26. 2013
    ....
  5. doi request reprint Pathologic features of antibody-mediated rejection in renal allografts: an expanding spectrum
    Mark Haas
    Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, California 91403, USA
    Curr Opin Nephrol Hypertens 21:264-71. 2012
    ..This review discusses recent findings that are changing and expanding the spectrum of pathologic changes associated with antibodies directed against renal allografts...
  6. ncbi request reprint C4d-negative antibody-mediated rejection in renal allografts: evidence for its existence and effect on graft survival
    M Haas
    Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Clin Nephrol 75:271-8. 2011
    ....
  7. doi request reprint Early ultrastructural changes in renal allografts: correlation with antibody-mediated rejection and transplant glomerulopathy
    M Haas
    Department of Pathology and Laboratory Medicine Biostatistics Core, Research Institute and General Clinical Research Center, Cedars Sinai Medical Center, Los Angeles, CA, USA
    Am J Transplant 11:2123-31. 2011
    ..5-30 months posttransplantation. Among the 18 patients with DSA and histologic changes of AMR, 11 C4d-positive and 7 C4d-negative, treatment for AMR after the early biopsy significantly reduced subsequent development of overt TG...
  8. doi request reprint Glomerular diseases associated with hematopoietic neoplasms: an expanding spectrum
    Mark Haas
    Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    Kidney Int 80:701-3. 2011
    ..Whether earlier recognition of glomerular diseases associated with hematopoietic neoplasms can result in more effective treatment remains an important question...
  9. doi request reprint The significance of C4d staining with minimal histologic abnormalities
    Mark Haas
    Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    Curr Opin Organ Transplant 15:21-7. 2010
    ..The significance of such C4d staining remains a topic of debate, and this finding may have different implications in ABO-incompatible versus conventional renal allografts...
  10. doi request reprint Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies on graft outcome
    Nancy L Reinsmoen
    1 HLA Laboratory, Cedars Sinai Medical Center, Los Angeles, CA 2 Biostatistics Core, Research Institute and General Clinical Research Center and Cardiothoracic Surgery, Cedars Sinai Medical Center, Los Angeles, CA 3 MD Anderson Medical Center, Houston, TX 4 Pathology, Cedars Sinai Medical Center, Los Angeles, CA 5 Cedars Sinai Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA 6 Address correspondence to Nancy L Reinsmoen, Ph D, D ABHI HLA Laboratory, Cedars Sinai Medical Center, 8723 Alden Dr, SSB 197, Los Angeles, CA 90048
    Transplantation 97:595-601. 2014
    ..The aim of our study was to determine the impact of anti-AT1R-ab and anti-donor HLA-specific antibody (DSA) on clinical outcomes...
  11. doi request reprint Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization
    Ashley A Vo
    1 Kidney Transplant Program and Transplant Immunology, Cedars Sinai Medical Center, Los Angeles, CA 2 Division of Pediatric Nephrology, All India Institute of Medical Sciences, New Delhi, India 3 Department of Pathology, Cedars Sinai Medical Center, Los Angeles, CA 4 Biostatistics Core, Cedars Sinai Medical Center, Los Angeles, CA
    Transplantation 99:1423-30. 2015
    ..Desensitization with intravenous immunoglobulin and rituximab (I+R) significantly improves transplant rates in highly sensitized patients, but antibody-mediated rejection (ABMR) remains a concern...
  12. doi request reprint A phase I/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients
    Ashley A Vo
    1 Comprehensive Transplant Center, Cedars Sinai Medical Center, Los Angeles, CA 2 Immunogenetics Laboratory, University of Pittsburgh Medical Center, Pittsburgh, PA 3 Transplant Immunology Laboratory, Cedars Sinai Medical Center, Los Angeles, CA 4 HLA and Immunogenetics Laboratory, Cedars Sinai Medical Center, Los Angeles, CA 5 Department of Pathology, Cedars Sinai Medical Center, Los Angeles, CA
    Transplantation 99:299-308. 2015
    ..C1 inhibitor (C1-INH, Berinert) inhibits the classical and lectin pathways of C activation. We performed a randomized, placebo-controlled study using C1-INH in highly sensitized renal transplant recipients for prevention of AMR...
  13. doi request reprint Benefits of rituximab combined with intravenous immunoglobulin for desensitization in kidney transplant recipients
    Ashley A Vo
    1 Comprehensive Transplant Center, Transplant Immunotherapy Program, Cedars Sinai Medical Center, Los Angeles, CA 2 HLA Laboratory, Cedars Sinai Medical Center, Los Angeles, CA 3 Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, CA 4 Transplant Immunology Laboratory, Cedars Sinai Medical Center, Los Angeles, CA 5 Address correspondence to Stanley C Jordan, M D, David Geffen School of Medicine at UCLA and Kidney Transplant Program, Cedars Sinai Medical Center, Los Angeles, CA 90048
    Transplantation 98:312-9. 2014
    ..Desensitization protocols (DES) have evolved, but rigorous evaluation is lacking. Here, we examined the efficacy of rituximab as a DES agent in a placebo-controlled trial...
  14. doi request reprint Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients
    Nancy L Reinsmoen
    Cedars Sinai Medical Center, HLA Laboratory, Comprehensive Transplant Center, Los Angeles, CA 90048, USA
    Transplantation 90:1473-7. 2010
    ....
  15. doi request reprint An updated Banff schema for diagnosis of antibody-mediated rejection in renal allografts
    Mark Haas
    Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, California, USA
    Curr Opin Organ Transplant 19:315-22. 2014
    ..To introduce the updated Banff schema for antibody-mediated renal allograft rejection and related revisions to definitions within this schema agreed upon during and immediately subsequent to the 2013 Banff Conference on Allograft Pathology...
  16. doi request reprint Histopathologic features of transplant glomerulopathy associated with response to therapy with intravenous immune globulin and rituximab
    Joseph Kahwaji
    Kidney and Pancreas Transplant Program, Comprehensive Transplant Center, Cedars Sinai Medical Center, Los Angeles, CA, USA
    Clin Transplant 28:546-53. 2014
    ..Histopathologic scoring in kidney allograft biopsies with TG may help guide treatment. The combination of IVIG and rituximab appears to be beneficial in patients whose biopsies have moderate or severe microvascular injury...
  17. doi request reprint Morphologic markers of progressive immunoglobulin A nephropathy
    Mark Haas
    Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, CA, USA
    Adv Chronic Kidney Dis 19:107-13. 2012
    ..In this article we review the recent derivation of a simplified scoring system for IgA nephropathy and discuss potential integration of pathology scores into routine clinical care...
  18. pmc Report from a consensus conference on antibody-mediated rejection in heart transplantation
    Jon Kobashigawa
    Cedars Sinai Heart Institute, Los Angeles, California
    J Heart Lung Transplant 30:252-69. 2011
    ..Therefore, a consensus conference was organized to discuss the current status of antibody-mediated rejection (AMR) in heart transplantation...
  19. doi request reprint Unmasking a unique glomerular lesion
    Christine Vanbeek
    Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, California, USA
    Kidney Int 86:13-5. 2014
    ..Careful examination including ultrastructural analysis is essential for identifying diseases such as MGMID that may be misclassified by routine methods and ultimately require alternative techniques for accurate diagnosis. ..